HLA-DRB5
HLA class II histocompatibility antigen, DR beta 5 chain
Also known as: DRB5_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q30154
- Gene
- HLA-DRB5
- Ensembl
- ENSG00000198502
- Chromosome
- 6
- Canonical length
- 266 aa
- Protein class
- Human disease related genes, Predicted membrane proteins
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
HLA-DRB5 belongs to the HLA class II beta chain paralogues. This class II molecule is a heterodimer consisting of an alpha (DRA) and a beta (DRB) chain, both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells. The beta chain is approximately 26-28 kDa and its gene contains 6 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and exon 5 encodes the cytoplasmic tail. Within the DR molecule the beta chain contains all the polymorphisms specifying the peptide binding specificities. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. There are multiple pseudogenes of this gene. [provided by RefSeq, Feb 2020]
Canonical amino-acid sequenceUniProt
266 residues, UniProt reviewed canonical sequence.
>Q30154|HLA-DRB5
1 MVCLKLPGGS YMAKLTVTLM VLSSPLALAG DTRPRFLQQD KYECHFFNGT ERVRFLHRDI
61 YNQEEDLRFD SDVGEYRAVT ELGRPDAEYW NSQKDFLEDR RAAVDTYCRH NYGVGESFTV
121 QRRVEPKVTV YPARTQTLQH HNLLVCSVNG FYPGSIEVRW FRNSQEEKAG VVSTGLIQNG
181 DWTFQTLVML ETVPRSGEVY TCQVEHPSVT SPLTVEWRAQ SESAQSKMLS GVGGFVLGLL
241 FLGAGLFIYF KNQKGHSGLH PTGLVSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HLA-DRB5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 397 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 397 nTPM
- lung: 336 nTPM
- spleen: 215 nTPM
- stomach: 202 nTPM
- small intestine: 174 nTPM
- thymus: 154 nTPM
Single-cell type
- enterocytes: 627 nCPM
- cdc: 423 nCPM
- endometrial secretory cells: 363 nCPM
- macrophages: 284 nCPM
- conjunctival goblet cells: 129 nCPM
- microglia: 125 nCPM
Immune cell
- myeloid DC: 62 nTPM
- total PBMC: 52 nTPM
- intermediate monocyte: 35 nTPM
- classical monocyte: 29 nTPM
- naive B-cell: 26 nTPM
- memory B-cell: 23 nTPM
Brain region
- thalamus: 4.3 nTPM
- choroid plexus: 4 nTPM
- spinal cord: 3.1 nTPM
- white matter: 2.7 nTPM
- hypothalamus: 2.6 nTPM
- cerebral cortex: 2.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about HLA-DRB5.
Disease | ImmuneIEDB
Conditions an epitope on HLA-DRB5 was assayed in.
- multiple sclerosis T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.85
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.61
- DepMap mean gene effect
- 0.13
- DepMap dependency class
- none
OntologyGO
Biological processes
- adaptive immune response
- antigen processing and presentation of exogenous peptide antigen via MHC class II
- peptide antigen assembly with MHC class II protein complex
- positive regulation of immune response
- positive regulation of T cell activation
Molecular functions
Cellular components
- clathrin-coated endocytic vesicle membrane
- endocytic vesicle membrane
- ER to Golgi transport vesicle membrane
- extracellular exosome
- Golgi membrane
- late endosome membrane
- lumenal side of endoplasmic reticulum membrane
- lysosomal membrane
- MHC class II protein complex
- plasma membrane
- trans-Golgi network membrane
- transport vesicle membrane
Protein domainsUniProt · Pfam · InterPro
- MHC class II, beta chain, N-terminal
- Immunoglobulin/major histocompatibility complex, conserved site
- Immunoglobulin C1-set
- Immunoglobulin-like domain
- MHC classes I/II-like antigen recognition protein
- Immunoglobulin-like fold
- MHC class II, alpha/beta chain, N-terminal
- Immunoglobulin-like domain superfamily
- Major Histocompatibility Complex/Immunoglobulin
- Class II histocompatibility antigen, beta domain
- Immunoglobulin C1-set domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HLA-DRB5 as an antibody target. Whether an autoantibody or antibody against HLA-DRB5 could matter depends on whether native HLA-DRB5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HLA-DRB5 is annotated at the cell surface, where native HLA-DRB5 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label HLA-DRB5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...